Skip to main content
Equibles

SJS Investment Consulting Inc.

Position in EXEL — Exelixis, Inc.

CIK 1894302 SYLVANIA, OH
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$44,670
+$16,578 QoQ
Shares Held
821
+25.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#626
of 756 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $1,414,824 across 170 Biotechnology names. EXEL ranks #5 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SLS
SELLAS Life Sciences Group, Inc.
 40,000 $590,400
2 JAZZ
Jazz Pharmaceuticals plc
 840 $202,414
3 TNXP
Tonix Pharmaceuticals Holding Corp.
 10,204 $130,203
4 BMRN
Biomarin Pharmaceutical Inc
 877 $50,181
5 EXEL
Exelixis, Inc.
This page 		821 $44,670
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 59 $29,306
7 REGN
Regeneron Pharmaceuticals, Inc.
 47 $29,305
8 INCY
Incyte Corp
 208 $23,578

All Filings in EXEL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,670 821
2026-03-31 $28,092 655
2025-12-31 $29,716 678
2025-09-30 $1,362 33
2025-06-30 $1,454 33
2025-03-31 $1,809 49
2024-12-31 $1,498 45
2024-09-30 $1,401 54
2024-06-30 $1,213 54
2024-03-31 $1,281 54
2023-12-31 $1,295 54
2023-09-30 $1,223 56
2023-06-30 $1,031 54
2023-03-31 $1,067 55
2022-12-31 $802 50
2022-09-30 $533 34
2022-03-31 $181 8